Urinary tract cancer: state of the art

This supplement issue presents advances in knowledge of the main urological cancers from a multidisciplinary perspective. It opens with an in-depth overview of controversial issues in the diagnosis and treatment of prostate cancer, followed by a paper on animal models and preliminary experience with oral bropirimine in phase I-II trials. The next four presentations focus on superficial bladder cancer, and include an overview of recent literature and results from ongoing clinical trials. Further contributions demonstrate the importance of randomized clinical trials to the care of patients with bladder cancer and provide a complete review of the diagnosis and treatment of kidney cancer. The final papers deal with important, but often ignored, subjects: quality of life, statistical design of trials and health economics. Bringing together the expertise and experience of leading authorities, this issue is valuable reading for all those interested in optimizing the treatment of patients with urinary tract cancer.